Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of the study is to evaluate patient adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management
It is a prospective, randomized, controlled Study. Patients randomized in a 1:1 ratio to pharmacist counseling or standard of therapy prior to discharge.
Standard therapy: Nurses distribute a education pamphlet on diabetes.
Pharmacist Counseling includes but is not limited to:
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Pharmacist Counseling | Active Comparator | Pharmacist Counseling includes but is not limited to: Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic & non-glycemic goal levels Explaining the importance of compliance with medications & appointments Educating on the basics of nutrition and physical activity |
|
| Standard therapy | No Intervention | Standard therapy: Nurses distribute a education pamphlet on diabetes |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Pharmacist Counseling | Other | Pharmacist Counseling includes but is not limited to: Reviewing and explaining their medications (dosing, side effects, route) Reviewing symptoms and complications of hyper and hypoglycemia Defining glycemic & non-glycemic goal levels Explaining the importance of compliance with medications & appointments Educating on the basics of nutrition and physical activity |
| Measure | Description | Time Frame |
|---|---|---|
| Adherence with discharge diabetes medications up to 120 days following pharmacist counseling during hospital stay about diabetes self management | The primary efficacy endpoint will be the difference in rate of adherence with medications Adherence will be assessed at 30, 60, 90, and 120 days following discharge An average of the total adherence rate 120 days following discharge will be calculated as the primary outcome measure | up to 120 days |
| Measure | Description | Time Frame |
|---|---|---|
| Change in A1c after 90 days | A1c measure as % and lipid panel 90 days following pharmacist counseling
| up to 90 days |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Leon Fogelfeld, M.D. | John H. Stroger Hospital of Cook County, Division of Endocrinology | Principal Investigator |
| Mansi Shah, PharmD | John H. Stroger Hospital of Cook County, Department of Pharmacy | Principal Investigator |
| CaTanya Norwood, R.PH | John H. Stroger Hospital of Cook County, Department of Pharmacy | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| John H. Stroger Jr. Hospital of Cook County | Chicago | Illinois | 60612 | United States |
Not provided
| ID | Term |
|---|---|
| D003924 | Diabetes Mellitus, Type 2 |
| ID | Term |
|---|---|
| D003920 | Diabetes Mellitus |
| D044882 | Glucose Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
| Change in BP after 90 days |
BP in mm/Hg |
| up to 90 days |
| Change in lipids after 90 days | Lipid measurements in mg/dL | up to 90 days |
| D004700 | Endocrine System Diseases |